Systematic Review of Biologic Graft Use in Parastomal Hernia Repair

Overview

This systematic review evaluated the use of acellular collagen-based biologic grafts for parastomal hernia repair, analyzing recurrence and complication rates. Four retrospective studies including 57 patients were reviewed, showing a weighted pooled recurrence rate of 15.7% and wound-related complication rate of 26.7%.

Background

Parastomal hernias are common complications after ileostomy or colostomy, with rates up to 28% and 48%, respectively. They can cause pain, discomfort, pouching difficulties, and negatively impact body image. Surgical repair options include stoma relocation, direct suture repair, and reinforcement with prosthetic materials. Synthetic mesh reduces recurrence but raises concerns about erosion, fistula formation, and infection, especially near bowel and stoma. Biologic grafts, derived from acellular collagen matrices, offer potential advantages such as better biocompatibility and lower infection risk, but their high cost necessitates evidence of clinical benefit.

Data Highlights

Key Findings

• Four retrospective studies with a total of 57 patients met inclusion criteria for biologic graft repair of parastomal hernias.
• Follow-up duration ranged from 8.1 to 50.2 months, mostly assessed by clinical examination and in one study by CT imaging.
• The weighted pooled recurrence rate of parastomal hernia after biologic graft repair was 15.7%.
• The weighted pooled rate of wound-related complications was 26.7%, including infections and other wound issues.
• No perioperative mortality was reported in any of the included studies.
• Definitions of recurrence and detailed reporting of surgical techniques varied or were lacking across studies.

Clinical Implications

Biologic grafts may offer a viable alternative to synthetic mesh for parastomal hernia repair, potentially reducing infection risk due to their biocompatibility. However, recurrence and wound complication rates remain significant, and the high cost of biologic materials necessitates careful patient selection. Further high-quality studies with standardized outcome definitions are needed to clarify their role.

Conclusion

Current evidence from limited retrospective studies suggests biologic grafts have moderate recurrence and complication rates in parastomal hernia repair. More robust data are required to establish their comparative effectiveness and justify their cost.

References

1. Systematic Review of Biologic Graft Utilization in the Repair of Parastomal Hernias